Mankind Pharma 

₹2,682.95
20
-₹33.05-1.22% Thursday 10:00

统计数据

当日最高
-
当日最低
-
52周最高
-
52周最低
-
成交量
-
平均成交量
-
市值
1.09T
市盈率
55.45
股息收益率
-
股息
-

即将到来

收益

29Oct预期
Q2 2023
Q4 2023
Q1 2024
Q2 2024
下一个
9.62
11.11
12.6
14.09
预期每股收益
N/A
实际每股收益
N/A

人们还关注

此列表基于关注MANKIND.NSE的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.
Show more...
首席执行官
Mr. Ramesh C. Juneja
员工
19540
国家
IN
ISIN
INE634S01028

上市公司